News and Events
-
38th ACS National Medicinal Chemistry Symposium 23rd-26th June 2024
Location: Seattle, USA.
-
Kinase 2023
10th SCI/RSC Symposium on Kinase Inhibitor Design
-
Binding Kinetics and Mechanistic PK/PD modeling in early Drug Discovery. 27th -28th March 2023
Enzymlogic will be presenting its optimized kinetic profiling assays to identify reversible (KINETICfinder®) and irreversible compounds (COVALfinder®) at this 2-day event in Cambridge. The meeting will focus on the use of binding kinetics and mechanistic PK/PD modeling in informing early drug discovery decisions. Further, the deliberations will strive to delve deeper into the importance of…
-
ELRIG Drug Discovery 2022: Driving the next life science revolution
Enzymlogic will participate in Drug Discovery 2022: Driving the next life science revolution ELRIG’s annual Drug Discovery meeting. The meeting will be held from 4–5th October at the ExCel in London and aims to present cutting-edge advancements in screening, automation and high content imaging, and innovations in disease models, advances in cell and gene therapies,…
-
DYRK1A, related kinases & human disease conference
As the kickoff to the DYRK1A, related kinases & human disease conference in Saint-Malo, France on November 22nd approaches, the Enzymlogic team is becoming increasingly excited. We are proud to have been selected to give a Podium Presentation highlighting the company’s KINETICfinder® and COVALfinder® technologies. During the podium presentation, entitled “Hunting for effective drugs with…